Direct-to-Consumer Medical Testing: Exploring Opportunities & Challenges

The Centre for Personalised Medicine (CPM), University of Oxford held a day-long symposium exploring the evolving landscape of direct-to-consumer (DTC) medical testing. Bringing together academic experts, clinicians, industry innovators, and regulatory professionals, this event delved into the opportunities and challenges of DTC testing across hormone health and fertility, gut and nutrition, and genetics, and its broader impact on patients and the NHS. The day featured presentations and panel discussions, examining how these technologies are influencing, and may continue to shape, patient pathways, clinical practices, and patient-clinician relationships within healthcare. The programme also engaged with the ethical, philosophical, and regulatory implications of DTC medical testing, asking critical questions about evidence, oversight, and responsibility in a rapidly changing health consumer market and its impacts on the NHS. With contributions from thought leaders across medicine, ethics, philosophy, regulation, and industry, this event provided a timely platform for interdisciplinary dialogue on a topical issue in modern healthcare.

This event was structured around three key themes:

1. Developments in direct-to-consumer medical testing
2. Implications of direct-to-consumer medical testing for clinical practice and patient pathways
3. Ethical, philosophical, and regulatory considerations of direct-to-consumer medical testing